TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Rhythm Biosciences Ltd. ( (AU:RHY) ) has provided an update.
Rhythm Biosciences Ltd. announced the issuance of unquoted equity securities, specifically options expiring in 2027 and 2028. This move is part of an employee incentive scheme and is not intended for public trading on the ASX, indicating a strategy to motivate and retain key personnel. The issuance of these options could potentially enhance the company’s operational capabilities by aligning employee interests with long-term company goals.
The most recent analyst rating on (AU:RHY) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Rhythm Biosciences Ltd. stock, see the AU:RHY Stock Forecast page.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of medical diagnostics. The company is primarily engaged in creating products aimed at early detection of cancer, which positions it within a crucial segment of the healthcare market.
Average Trading Volume: 343,535
Technical Sentiment Signal: Buy
Current Market Cap: A$28.99M
For detailed information about RHY stock, go to TipRanks’ Stock Analysis page.